Loading...
Symbols:
Loading...
Symbols:
Cepheid (CPHD)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Cepheid (CPHD)
19 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on CPHD
- SA Editor Miriam Metzinger(11)
- Bespoke Investment Group(4)
- SA Editor Judy Weil(3)
- Centient Biotech Investor(2)
- Sara Calabro(2)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(572)
- Andrew Wilkinson(333)
- SA Editor Judy Weil(183)
- Zacks.com (127)
- SA Editor Miriam Metzinger(116)
Most commented on authors
- Best and Worst Performing Stocks on Earnings
- Be Selective with Medical Device Companies
- Cepheid: Stock Plunge Presents Buy Opportunity
- Second Quarter Earnings Season: Biggest Winners and Losers
- Bernanke, the Greatest Speculator - Fast Money (6/25/08)
- Cepheid Takes Hit on False MRSA Testing Claim
- Last Year's Best Stocks Have Been This Year's Worst
- Tuesday's Options Report: XLF, AIG, ALB, THRX, SGP, CPHD, IGT, PDE
- 2007's Best, Worst Performers Faring Poorly in 2008
- Cepheid: Is the MRSA Infection an Investment Opportunity?
- Can Cepheid Power Past $25?
- Time to Buy Molecular Diagnostics Company Cepheid
- Four Molecular Diagnostics Companies With An Edge
- FDA Approves Cepheid’s Test For Infectious Bacteria
- Neurochem Announcement Lowers Alzhemed Expectations - Barron's
- Cepheid's Buyout Attractions are Overrated - Barron's
- Veteran's Administration Contractors: A Good Investment - Barron's
- Biotech Day in Review: FluMist from MedImmune Outperforms Injected Vaccine
- Biotech Stocks Day-in-Review: Lilly Drug Effective In Pancreatic Cancer
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »